Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Taiho Oncology, Inc.
Taiho Oncology Announces New England Journal of Medicine Publication of First All-Oral Regimen in Newly Diagnosed Acute Myeloid Leukemia
June 03, 2026
From
Taiho Oncology, Inc.
Via
Business Wire
U.S. FDA Approves INQOVI® in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy
May 13, 2026
From
Taiho Oncology, Inc.
Via
Business Wire
U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
April 28, 2026
From
Taiho Oncology, Inc.
Via
Business Wire
Tickers
CGEM
Taiho Oncology Appoints Peter Melnyk as President & Chief Executive Officer
January 28, 2026
From
Taiho Oncology, Inc.
Via
Business Wire
Peter Melnyk Joins Taiho Oncology as President & Chief Operating Officer
January 20, 2026
From
Taiho Oncology, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.